2 unknown, 1 completed. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Completed 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow trofosfamide: new trials by email Literature Review of trofosfamide trials Research Report on trofosfamide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma dacarbazine (DTIC), Trofosfamide, Etoricoxib, Pioglitazone, Temsirolimus - Advanced Melanoma | Phase 1 / Phase 2 | Unknown | University of Regensburg | 136 | 2012-05-01 | 2012-06-07 |
| Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children carboplatin, etoposide, temozolomide - Recurrent Brain Tumors, Supratentorial PNETs | Phase 2 / Phase 3 | Completed | University Hospital, Bonn | 174 | 2006-02-01 | 2018-07-20 |
| Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS) Adriamycin, Trofosfamide - Sarcoma, Soft Tissue | Phase 2 | Unknown | University Hospital Schleswig-Holstein | 117 | 2004-08-01 | 2013-01-08 |
Brain Neoplasms (1) · Ependymoma (1) · Medulloblastoma (1) · Recurrence (1) · Sarcoma (1)
University Hospital Schleswig-Holstein (1) · University Hospital, Bonn (1) · University of Regensburg (1)
Germany (3)
Albrecht Reichle, Professor (1) · Gudrun Fleischhack, MD (1) · Joerg T. Hartmann, MD (1)